Skip to main content
NIH funding notice RFA-EB-23-002

NIBIB Biomaterials Network Technology Development Coordinating Center (U24 Clinical Trial Not Allowed)

Closed on May 31, 2023.

Posted
March 14, 2023
Close date
May 31, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,057,647 in first-year total cost, median $1,057,647.

Most frequent study sections

  1. Special Emphasis Panel[ZEB1 OSR-E (J2)]1

Most frequent institutions

  1. UNIVERSITY OF MICHIGAN AT ANN ARBOR1
Competing awards under RFA-EB-23-002 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2024Humanity Unlocking Biomaterials (HUB) Coordinating Center1U24EB035897-01ENIOLA-ADEFESO, OMOLOLASTEVENS, KELLY RUNIVERSITY OF MICHIGAN AT ANN ARBOR, MI$1,057,647ZEB1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.